Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 6055), Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6004), New York
Memorial Sloan Kettering Cancer Center ( Site 6053), New York

Тражи се учесникФаза 3

Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT06952504

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

START New York Long Island, LLC, Lake Success
Columbia University Irving Medical Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07503808

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06515613

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Northwell Health Imbert Cancer Center, Bay Shore
Memorial Sloan Kettering Commack, Commack
Northwell Health Physician Partners at Flushing, Flushing
и још 20

Тражи се учесникФаза 3

Узраст 18 и старији · Жене · Ажурирано 6. 11. 2026. · NCT07198074

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

The Woman's Health Pavilion, Howard Beach
The Woman's Health Pavilion, Westbury

Тражи се учесникОпсервациона студија

Узраст 18 и старији · Жене · Ажурирано 5. 11. 2026. · NCT05051722

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NYU Langone Health - Long Island, Mineola
New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06400472

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07114601

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
Memorial Sloan Kettering Cancer Center, New York
и још 1

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT04165772

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Northwell Health Cancer Institute, Lake Success
Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06695845

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

NYU Laura and Isaac Perlmutter Cancer Center - 34th Street, New York
Perlmutter CC NYU Langone LI, New York

Тражи се учесникФаза 3

Узраст 18 и старији · Жене · Ажурирано 3. 11. 2026. · NCT07166094

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

START New York-Long Island, Lake Success
Memorial Sloan Kettering Cancer Center (MSKCC), New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07262619

Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

New York Oncology Hematology, Albany
White Plains Hospital, White Plains

Тражи се учесникФаза 3

Узраст 18 и старији · Жене · Ажурирано 30. 10. 2026. · NCT07578649

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Roswell Park Comprehensive Cancer Center, Buffalo
Mount Sinai Tisch Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NYU Langone Health, New York
Icahn School of Medicine At Mount Sinai Prime, New York
Clinical Research Alliance, Inc, Westbury
и још 1

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06330064

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

A Phase 1 Study of the Safety and Tolerability of CTX-10726

START New York, Lake Success

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07419841

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Hematology Oncology Associates of Central New York, East Syracuse
Northwell Health Cancer Institute, Lake Success
Memorial Sloan-Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

Memorial Sloan Kettering Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
и још 1

Тражи се учесникФаза 2

Узраст 18 и старији · Жене · Ажурирано 15. 10. 2026. · NCT04774419

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07186842

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Start (Nyli), Lake Success
NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06293898

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Commack

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05123482

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, New York

Тражи се учесникФаза 3

Узраст 18 и старији · Жене · Ажурирано 13. 10. 2026. · NCT06989112

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Icahn School of Medicine at Mount Sinai, New York
Montefiore Einstein Comprehensive Cancer Center, The Bronx

Тражи се учесникФаза 1

Узраст 15 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06276491

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

START Center for Cancer Research - Long Island New York, Lake Success
Mount Sinai, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

Тражи се учесникФаза 1/2

Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Mineola
Avenzo Therapeutics Recruiting Site, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT05867251

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Жене · Ажурирано 25. 9. 2026. · NCT03564340

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
и још 1

Тражи се учесник

Узраст 18 и старији · Жене · Ажурирано 25. 9. 2026. · NCT07270666

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Жене · Ажурирано 24. 9. 2026. · NCT04590326

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Commack

Тражи се учесникФаза 2

Узраст од 18 до 130 · Оба пола · Ажурирано 23. 9. 2026. · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06128551

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.